SCHEMBL8768860

SCHEMBL8768860

CC(C)(C)[Si](C)(C)Oc1ccc([C@H]2C[C@]3(C)C(O[Si](C)(C)C)=CC[C@H]3[C@@H]3CC=C4CC5(CC[C@@H]4[C@H]32)OCCO5)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8769024 0.90 PGR (0.30) —
SCHEMBL8654083 0.86 MAPT (0.42) —
SCHEMBL8767917 0.83 — —
SCHEMBL8948872 0.81 — —
SCHEMBL8767729 0.76 — —
SCHEMBL9171310 0.76 NR3C1 (0.30) —
SCHEMBL8653835 0.74 MAPT (0.46) —
SCHEMBL9174030 0.73 MAPT (0.42) —
SCHEMBL8407252 0.73 PGR (0.37) —
SCHEMBL9178008 0.71 POLB (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567469-B1 14beta-H-, 14- AND 15-EN-11beta-ARYL-4-ESTRENES SCHERING AG (DE) 1997-08-27 — — EP disclosed
US-5426102-A Antigestagenic, antiandrogenic, antiglucocorticoid, antimineralcorticoid properties SCHERING AKTIENGESELLSCHAFT (DE) 1995-06-20 — — US disclosed
Send feedback